Thrombophilia in patients with chronic venous leg ulcers-a study on patients with or without post-thrombotic syndrome

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 12, 2011, Pages 1432-1439

  Zutt, M ^a   Kruger U ^a   Rosenberger, A ^a   Schon M P ^a   Neumann, C ^a   Von Ahsen, N ^a   Kretschmer, L ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; CYANOCOBALAMIN; HOMOCYSTEINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN; PYRIDOXINE;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ANTITHROMBIN DEFICIENCY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; INTRAVASCULAR ULTRASOUND; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; THROMBOPHILIA; VARICOSE ULCER;

EID: 81155137881     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04001.x     Document Type: Article

References (39)

1. Rabe E, Pannier-Fischer F, Bromen K,. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie- epidemiologische Untersuchung zur Frage der Häufigkeit und Ausprägung von chronischen Venenkrankheiten in der städtischen und ländlichen Wohnbevölkerung. Phlebologie 2003; 32: 1-14. (Pubitemid 36389284)
2. Bradbury AW, MacKenzie RK, Burns P, et al. Thrombophilia and chronic venous ulceration. Eur J Vasc Endovasc Surg 2002; 24: 97-104. (Pubitemid 41079363)
3. Gaber Y, Siemens HJ, Schmeller W,. Increased prevalence of APC-resistance (factor V Leiden mutation) in patients with postthrombotic syndrome. Hautarzt 2000; 51: 590-592. (Pubitemid 30629227)
4. Gaber Y, Siemens HJ, Schmeller W,. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers. Br J Dermatol 2001; 144: 546-548. (Pubitemid 32232009)
5. Mackenzie RK, Ludlam CA, Ruckley CV, et al. The prevalence of thrombophilia in patients with chronic venous leg ulceration. J Vasc Surg 2002; 35: 718-722.
6. Munkvad S, JÃrgensen M,. Antithrombin-III plasma levels in patients with venous leg ulcer disease. Acta Derm Venereol 1995; 75: 251.
7. Munkvad S, JÃrgensen M,. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol 1996; 134: 296-298. (Pubitemid 26053587)
8. Darvall KA, Sam RC, Adam DJ, et al. Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls. J Vasc Surg 2009; 49: 1235-1241.
9. Spiezia L, Campello E, Giolo E, Villalta S, Prandoni P,. Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation. J Thromb Haemost 2010; 8: 211-213.
10. Delluc A, Gouedard C, De Saint Martin L, et al. Incidence, risk factors and skin manifestations of post-thrombotic syndrome: a four-year follow-up of patients included in the EDITH study. Rev Med Interne 2010; 31: 729-734.
11. Kistner RL, Eklof B, Masuda EM,. Diagnosis of chronic venous disease of the lower extremities: the "CEAP" classification. Mayo Clin Proc 1996; 71: 338-345.
12. Hach W, Hach-Wunderle V,. Phlebographie der Bein-und Beckenvenen. 4. Schnetztor-Verlag, Auflage, 1996.
13. Neuerer G,. Die Phlebographie der Unteren Extremität; Partsch H. Phlebologiekurs, 5teilige Fortbildungsreihe der âArbeitsgemeinschaft Phlebologie der Ãsterreichischen Gesellschaft für Dermatologie und Venerologie". 1. Zymaâ¢VenorutonÂ-Service, Auflage, 1989; C/1/S6-C/1/S8.
14. von Ahsen N, Oellerich M, Schütz E,. A method for homogeneous color-compensated genotyping of factor V (G1691A) and methylenetetrahydrofolate reductase (C677T) mutations using real-time multiplex fluorescence pcr. Clin Biochem 2000; 7: 535-539. (Pubitemid 32011861)
15. von Ahsen N, Schütz E, Armstrong VW, et al. Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem 1999; 45: 694-696. (Pubitemid 29220337)
16. Faden D, Tincani A, Tanzi P, et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 73: 37-42. (Pubitemid 27224458)
17. Seligsohn U, Lubetsky A,. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-1231. (Pubitemid 32319498)
18. De Stefano V, Rossi E, Paciaroni K, et al. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002; 87: 1095-1108. (Pubitemid 35192223)
19. Ribeaudeau F, Senet P, Cayuela JM, et al. Prospective coagulation study including resistance to activated protein C and mutations in factors V and II in venous leg ulcers. Br J Dermatol 1999; 141: 259-263. (Pubitemid 29397993)
20. Brandt HR, de Lorenzo Messina MC, Hirayama JT, et al. Prevalence of thrombophilia associated with leg ulcers. Br J Dermatol 2009; 160: 259-263.
21. Middeldorp S, van Hylckama Vlieg A,. Does thrombophilia testing help in the clinical management of patients? Br J Haematol 2008; 143: 321-335.
22. Falanga V, Bontempo FA, Eaglstein WH,. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol 1990; 126: 1195-1197. (Pubitemid 20292680)
23. Joffe HV, Goldhaber SZ,. Laboratory thrombophilias and venous thromboembolism. Vasc Med 2002; 7: 93-102. (Pubitemid 35203357)
24. Munkvad S, JÃrgensen M,. Activated protein C resistance in patients with venous leg ulcer. Ugeskr Laeger 1997; 159: 2100-2102.
25. Hafner J, Felten A,. Resistance to activated protein C in patients with venous leg ulcers. Dermatology 1997; 195: 413-414. (Pubitemid 28017831)
26. Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med 1996; 100: 530-536. (Pubitemid 26170477)
27. Greaves M,. Antiphospholipid antibodies and thrombosis. Lancet 1999; 353: 1348-1353. (Pubitemid 29178795)
28. Galli M, Luciani D, Bertolini G, et al. Anti-Ã2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 102: 2717-2723. (Pubitemid 37248837)
29. Lindhoff-Last E, Luxembourg B,. Vasa. Evidence-based indications for thrombophilia screening. Vasa 2008; 37: 19-30. (Pubitemid 351341137)
30. Grossman D, Heald PW, Wang C, et al. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers. J Am Acad Dermatol 1997; 37: 409-413. (Pubitemid 27430638)
31. Alcaraz I, Levfevre I, Wiart T, et al. Leg ulcers and antiphospholipid antibodies. Prospective study of 48 cases. Annal Dermatol et de Venereol 1999; 126: 313-316. (Pubitemid 29304774)
32. Cattaneo M,. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999; 81: 165-176. (Pubitemid 29078298)
33. Franco RF, Reitsma PH,. Genetic risk factors of venous thrombosis. Hum Genet 2001; 109: 369-384. (Pubitemid 33064516)
34. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004; 50: 3-32. (Pubitemid 38125696)
35. Robetorye RS, Rodgers GM,. Update on selected inherited venous thrombotic disorders. Am J Hematol 2001; 68: 256-268. (Pubitemid 33108429)
36. Bauer KA,. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med 2001; 135: 367-373. (Pubitemid 32823243)
37. Combemale P, Amiral J, Estival JL, et al. Cutaneous necrosis revealing the coexistence of an antiphospholipid syndrome with acquired protein S deficiency, factor V Leiden and hyperhomocysteinemia. Eur J Dermatol 2002; 12: 278-282. (Pubitemid 34454661)
38. Kolbach DN, Veraart JC, Hamulyák K,. Recurrent leg ulcers in a young man with hyperhomocysteinemia, factor V Leiden and impaired fibrinolysis. Acta Derm Venereol 2002; 82: 52-54. (Pubitemid 34450546)
39. Sam RC, Burns PJ, Hobbs SD, et al. The prevalence of hyperhomocysteinemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency. J Vasc Surg 2003; 38: 904-908. (Pubitemid 37409620)